Dynavax Technologies (DVAX)

$15.63 +0.01 (0.06%)
Market Cap 1.83B
Revenue (ttm) 277.25M
Net Income (ttm) 27.31M
EPS (ttm) N/A
PE Ratio 53.79
Forward PE 24.96
Profit Margin 9.85%
Debt to Equity Ratio 0.08
Volume 1,836,200
Avg Vol 3,299,296
Day's Range N/A - N/A
Shares Out 117.43M
Stochastic %K 71%
Beta 0.89
Analysts Sell
Price Target $21.00

Company Profile

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also develops rF1V, a plague vaccine candidate in Phase 2 clinical trial; and Z-1018, an investigational vaccin...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 510 848 5100
Fax: 510 848 1327
Address:
2100 Powell Street, Suite 720, EmeryVille, United States
KWalzz
KWalzz Jan. 17 at 12:46 PM
$DVAX just a note: this not about a "proxy vote" as someone stated here yesterday, it is simply about the tender offer details (TO-T) Dynavax filed on 01/12 and already known. volume is very low for a tender offer ending 02/09. let's see if it goes through so easily.
0 · Reply
DaPod
DaPod Jan. 17 at 10:39 AM
$DVAX Here is link to the DVAX Proxy Document It is 83 pages long. https://reorgdocumentlibrary.broadridge.com/Client/Client?data=0126/E63914/268158201/c
0 · Reply
KWalzz
KWalzz Jan. 16 at 8:54 PM
$DVAX the volume is so low ....
0 · Reply
Dilly_Due
Dilly_Due Jan. 16 at 5:55 PM
$DVAX Anyone happen to have a copy of the doc. that DaPod rcvd this moring? Thanks!
0 · Reply
Dilly_Due
Dilly_Due Jan. 16 at 4:00 PM
$LLY $MRK $JNJ $DVAX $VXRT OK, so whoever is the DVAX "3rd party" can you please hurry up and make a counter offer? VAAST needs to stay in the US!
1 · Reply
KWalzz
KWalzz Jan. 16 at 1:51 PM
$DVAX Novack is most likely retiring and keen to sell his shares and options as fast as possible. Maybe he sees the ongoing class action efforts as real threat. I think he may be right but it is too soon to really state this. However I hold onto my shares, there is no rush and risk now ...
1 · Reply
KWalzz
KWalzz Jan. 16 at 1:41 PM
$DVAX the only update re Dynavax is: NOVACK files a Form 144. Is he desperate to sell as fast as possible? This guy is such a piece of .... . LOL
0 · Reply
DaPod
DaPod Jan. 16 at 12:45 PM
$DVAX Well they sure did not waste any time before sending out the email to vote on the merger. Getting proxy stuff by email as I opened my email today there it was - the DVAX proxy vote. Have not bothered to read it yet but sure it is just a cut and dried voting form. Guess they want to get it done before there can be any more organized - if there was any - attempts to stop the merger. Had thought that Deep Track might have mat least made some statement or hoped they would take some action to stop this BO. There are often a group of law firms that automatically jump on mergers and other events they feel can earn them some fees, but not sure people joining these suits really ever get any help or change from these firms. Any new thoughts with the proxy vote form now out?
1 · Reply
Dilly_Due
Dilly_Due Jan. 15 at 4:54 PM
$VXRT $DVAX What would a grant from BARDA or Gates Foundation to conduct Noro Phase II trial take the VXRT stock price to? If what others are saying about ATM's not allowed on OTC, would that mean that Lo could not do what he did just after the BARDA Covid funding announcement? Would it affect the potential for a counter bid for DVAX?
1 · Reply
KWalzz
KWalzz Jan. 15 at 3:31 PM
$DVAX is 15.50 a right price? class action attorneys do not think it is. arbitrage funds? where are they? volume? where is it? still no 13D/A out, what does Deep Track Capital etc. think? we will see ...
1 · Reply
Latest News on DVAX
Shares of Dynamax Are Up Nearly 40% Today. Here's Why The Stock Is Flying

Dec 24, 2025, 11:05 AM EST - 23 days ago

Shares of Dynamax Are Up Nearly 40% Today. Here's Why The Stock Is Flying

This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion.

Dec 24, 2025, 7:59 AM EST - 24 days ago

This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion.

SNY

Sanofi to acquire Dynavax for $2.2B, sending shares higher by 37%

Dec 24, 2025, 6:49 AM EST - 24 days ago

Sanofi to acquire Dynavax for $2.2B, sending shares higher by 37%

Sanofi to acquire US biotech Dynavax for $2.2 billion

Dec 24, 2025, 3:08 AM EST - 24 days ago

Sanofi to acquire US biotech Dynavax for $2.2 billion

SNY

Sanofi to Buy Vaccine Maker Dynavax in $2.2 Billion Deal

Dec 24, 2025, 1:49 AM EST - 24 days ago

Sanofi to Buy Vaccine Maker Dynavax in $2.2 Billion Deal

SNY

Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline

Dec 24, 2025, 1:23 AM EST - 24 days ago

Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline

Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline

Dec 24, 2025, 1:15 AM EST - 24 days ago

Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline

SNY

Dynavax to Participate at the 8th Annual Evercore Healthcare Conference

Nov 19, 2025, 4:01 PM EST - 2 months ago

Dynavax to Participate at the 8th Annual Evercore Healthcare Conference

Dynavax Technologies Corporation (DVAX) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 10:31 PM EST - 2 months ago

Dynavax Technologies Corporation (DVAX) Q3 2025 Earnings Call Transcript

Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program

Nov 5, 2025, 4:01 PM EST - 2 months ago

Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program

VXRT

Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program

Nov 5, 2025, 4:00 PM EST - 2 months ago

Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program

VXRT

Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025

Oct 22, 2025, 4:01 PM EDT - 3 months ago

Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025

Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial

Oct 21, 2025, 4:01 PM EDT - 3 months ago

Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial

3 Of My Favorite Biotech Stocks Under $10

Sep 29, 2025, 1:15 PM EDT - 3 months ago

3 Of My Favorite Biotech Stocks Under $10

FOLD MRNA NUVB PFE

Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference

Aug 27, 2025, 4:05 PM EDT - 5 months ago

Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference

Dynavax's shingles vaccine shows similar immune response to GSK's shot in study

Aug 21, 2025, 8:22 AM EDT - 5 months ago

Dynavax's shingles vaccine shows similar immune response to GSK's shot in study

GSK

Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile

Aug 21, 2025, 8:00 AM EDT - 5 months ago

Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile

Dynavax Technologies: A Dip To Accumulate

Aug 11, 2025, 8:41 AM EDT - 5 months ago

Dynavax Technologies: A Dip To Accumulate

Dynavax Technologies Corporation (DVAX) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 10:51 PM EDT - 5 months ago

Dynavax Technologies Corporation (DVAX) Q2 2025 Earnings Call Transcript

Dynavax Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:00 PM EDT - 5 months ago

Dynavax Reports Second Quarter 2025 Financial Results

Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

Jul 29, 2025, 4:02 PM EDT - 6 months ago

Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

Dynavax elects all four of its nominees after Deep Track proxy fight

Jun 11, 2025, 12:14 PM EDT - 7 months ago

Dynavax elects all four of its nominees after Deep Track proxy fight

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

Jun 11, 2025, 11:01 AM EDT - 7 months ago

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

Jun 9, 2025, 8:30 AM EDT - 7 months ago

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

Jun 9, 2025, 7:30 AM EDT - 7 months ago

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

Dynavax Comments on Glass Lewis Recommendation

Jun 4, 2025, 4:59 PM EDT - 8 months ago

Dynavax Comments on Glass Lewis Recommendation

Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies

Jun 4, 2025, 9:27 AM EDT - 8 months ago

Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

May 28, 2025, 4:10 PM EDT - 8 months ago

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

Deep Track Capital Comments on ISS Recommendation

May 23, 2025, 6:12 PM EDT - 8 months ago

Deep Track Capital Comments on ISS Recommendation

ISS backs Dynavax directors in board fight with Deep Track Capital

May 23, 2025, 1:54 PM EDT - 8 months ago

ISS backs Dynavax directors in board fight with Deep Track Capital

Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees

May 23, 2025, 1:44 PM EDT - 8 months ago

Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees

Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good

May 21, 2025, 11:48 PM EDT - 8 months ago

Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good

Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting

May 15, 2025, 4:00 PM EDT - 8 months ago

Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value

May 12, 2025, 7:30 AM EDT - 8 months ago

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value

Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum

May 7, 2025, 4:45 PM EDT - 9 months ago

Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum

Dynavax Technologies Corporation (DVAX) Q1 2025 Earnings Call Transcript

May 6, 2025, 7:34 PM EDT - 9 months ago

Dynavax Technologies Corporation (DVAX) Q1 2025 Earnings Call Transcript

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs

May 6, 2025, 4:01 PM EDT - 9 months ago

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs

Deep Track Capital Releases Investor Presentation on Dynavax Technologies

May 6, 2025, 8:00 AM EDT - 9 months ago

Deep Track Capital Releases Investor Presentation on Dynavax Technologies

Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits

May 1, 2025, 8:00 AM EDT - 9 months ago

Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits

Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy

Apr 29, 2025, 7:30 AM EDT - 9 months ago

Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy

Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

Apr 22, 2025, 4:00 PM EDT - 9 months ago

Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Apr 21, 2025, 4:05 PM EDT - 9 months ago

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders

Apr 17, 2025, 7:15 AM EDT - 9 months ago

Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders

Deep Track Capital Comments on Dynavax Technologies' Rejection of Most Recent Settlement Offer

Apr 16, 2025, 8:00 AM EDT - 9 months ago

Deep Track Capital Comments on Dynavax Technologies' Rejection of Most Recent Settlement Offer

Dynavax Files Preliminary Proxy Statement

Apr 3, 2025, 5:40 PM EDT - 10 months ago

Dynavax Files Preliminary Proxy Statement

KWalzz
KWalzz Jan. 17 at 12:46 PM
$DVAX just a note: this not about a "proxy vote" as someone stated here yesterday, it is simply about the tender offer details (TO-T) Dynavax filed on 01/12 and already known. volume is very low for a tender offer ending 02/09. let's see if it goes through so easily.
0 · Reply
DaPod
DaPod Jan. 17 at 10:39 AM
$DVAX Here is link to the DVAX Proxy Document It is 83 pages long. https://reorgdocumentlibrary.broadridge.com/Client/Client?data=0126/E63914/268158201/c
0 · Reply
KWalzz
KWalzz Jan. 16 at 8:54 PM
$DVAX the volume is so low ....
0 · Reply
Dilly_Due
Dilly_Due Jan. 16 at 5:55 PM
$DVAX Anyone happen to have a copy of the doc. that DaPod rcvd this moring? Thanks!
0 · Reply
Dilly_Due
Dilly_Due Jan. 16 at 4:00 PM
$LLY $MRK $JNJ $DVAX $VXRT OK, so whoever is the DVAX "3rd party" can you please hurry up and make a counter offer? VAAST needs to stay in the US!
1 · Reply
KWalzz
KWalzz Jan. 16 at 1:51 PM
$DVAX Novack is most likely retiring and keen to sell his shares and options as fast as possible. Maybe he sees the ongoing class action efforts as real threat. I think he may be right but it is too soon to really state this. However I hold onto my shares, there is no rush and risk now ...
1 · Reply
KWalzz
KWalzz Jan. 16 at 1:41 PM
$DVAX the only update re Dynavax is: NOVACK files a Form 144. Is he desperate to sell as fast as possible? This guy is such a piece of .... . LOL
0 · Reply
DaPod
DaPod Jan. 16 at 12:45 PM
$DVAX Well they sure did not waste any time before sending out the email to vote on the merger. Getting proxy stuff by email as I opened my email today there it was - the DVAX proxy vote. Have not bothered to read it yet but sure it is just a cut and dried voting form. Guess they want to get it done before there can be any more organized - if there was any - attempts to stop the merger. Had thought that Deep Track might have mat least made some statement or hoped they would take some action to stop this BO. There are often a group of law firms that automatically jump on mergers and other events they feel can earn them some fees, but not sure people joining these suits really ever get any help or change from these firms. Any new thoughts with the proxy vote form now out?
1 · Reply
Dilly_Due
Dilly_Due Jan. 15 at 4:54 PM
$VXRT $DVAX What would a grant from BARDA or Gates Foundation to conduct Noro Phase II trial take the VXRT stock price to? If what others are saying about ATM's not allowed on OTC, would that mean that Lo could not do what he did just after the BARDA Covid funding announcement? Would it affect the potential for a counter bid for DVAX?
1 · Reply
KWalzz
KWalzz Jan. 15 at 3:31 PM
$DVAX is 15.50 a right price? class action attorneys do not think it is. arbitrage funds? where are they? volume? where is it? still no 13D/A out, what does Deep Track Capital etc. think? we will see ...
1 · Reply
DaPod
DaPod Jan. 15 at 1:49 PM
$DVAX Looking at Yahoo Finance this morning saw that Creamer had put out a comment on DVAX and Sanofi Jim Cramer Highlights Sanofi’s Bid for Dynavax https://finance.yahoo.com/news/jim-cramer-highlights-sanofi-bid-155740049.html Thought you might find it interesting Will Add -Not a Creamer fan!! But he does get attention!!!
0 · Reply
Vanderm98
Vanderm98 Jan. 15 at 12:30 PM
$ALT Somene get Sanofi over here. They are fondling my jewels $DVAX $OCUL I have four though $ALT $VSTM GL!!
0 · Reply
Vanderm98
Vanderm98 Jan. 15 at 12:13 PM
$OCUL Sanofi shops like I do. They stole $DVAX for 15.5 and tried to grab this one for 16. Glad they said No. DVAX should have as well. I may hold if they give shares. They’re juicing the 28’ pipeline. GL
1 · Reply
KWalzz
KWalzz Jan. 14 at 3:54 PM
$DVAX is something going on behind-the-scenes? there are some very subtle signs showing up currently ... but I would not bet on it ... I have my take on the proceedings since the TO-T is out, the language in it regarding Spencer's "hard negotiations" is laughable at best ... it is only about a first defense line re class actions and ligitations but it is all very weak imo = a Spencer&Myers as we know them. but maybe DVAX is not worth more, I for myself saw the CpG1018 thing for some years much exaggerated by paid pumpers. all the best to my fellow traders here ...
1 · Reply
Noobnr1
Noobnr1 Jan. 14 at 3:43 PM
$DVAX BO 15,5 trading a bit higher… in my opinion 15,5 is to low 😄 give us some more 💵💸🤑
0 · Reply
AccuRoger
AccuRoger Jan. 14 at 2:37 PM
$DVAX This is new human trial data. As far as I know, UVAX did not proceed with a further trial using Cpg 1018. Interesting detail for the new owners. https://pmc.ncbi.nlm.nih.gov/articles/PMC12792061/
0 · Reply
Dilly_Due
Dilly_Due Jan. 14 at 12:42 PM
$VXRT $DVAX Prediction: I believe Dynavax receives a new, higher bid. Reasons: 1) Sanofi was in talks to buy DVAX BEFORE most recent DVAX earnings call (theory, but unproven). 2) The upside to the VAAST platform (if successful) has MUCH more potential than an approved Hep B vaccine with sig. competition. 3) Assuming VXRT can discern which vax participants rcvd from the data (believe true), it's logical they would leverage this to pitch to BP to extend their cash runway. 4) DVAX doesn't buy VXRT covid rights without direction/approval from an acquiring firm. Listen to the analyst Q from the DVAX earnings call and his reaction to the answer. 5) The rumor since Friday seems to be growing and the stock price continues to trade into the low $15.70's (above the current $15.5 offer from Sanfi). So who will counter? Pred. Lilly. Barda wants a platform. Current admin. respects market cap and wants US ownership. (10x MC and US (Lilly) vs France (Sanofi). Just my humble opinion. Do your own DD.
1 · Reply
Chalutz
Chalutz Jan. 13 at 9:29 PM
$VXRT Pure speculation on my part. DYOD and MYODs. But if I had to bet that FN Sentinel Cohort Data is a available and these MFKRs are holding it to keep their share price down and $DVAX from getting a higher bid from another party. They’ve already cut some deal with Sanofi to help them screw retail out of their shares so they can load up themselves. Remember these are the same MFKRs who did an AH dilution after BARDA PR to wipe us out. Make some noise. Who at FN SEC is watching them? Sanofi and DVAX BOD/MGMT are working with VXRT to help screw us. Make noise. Where is those results? Why hasn’t it been released?
2 · Reply
MACTEP
MACTEP Jan. 13 at 8:29 PM
$DVAX the “deal” is doomed now 😬
0 · Reply
AccuRoger
AccuRoger Jan. 13 at 8:25 PM
$DVAX shares traded above the buyout price for the past couple of days only. Some retail investors think it signals another bid. I disagree. I read through the boring SEC documents that were posted this week. The purpose is to close the deal by mid-February. The documents specify how shares will be exchanged for cash. The small increase in the share price seems related to the COVERED CALL option of about four million shares and the resolution of the outstanding debt. The counter parties were due a bonus payment upon a change of control. This is fancy arbitrage stuff that gets worked out by the sponsoring bank. Retail investors have zero access to the timing or the details. However, you can choose to take advantage of the small share price premium if you agree with my assessment. I do not think it will be available for very long. Or, wait for the official closing of the buyout. Shaking your virtual fist at management does not improve your chances for gain.
1 · Reply
HeadlessHorsemen
HeadlessHorsemen Jan. 13 at 7:27 PM
$DVAX Hello Everyone!!!. Didn't think I would be posting on this LOS stock again; but Myers/Spenser never cease to amaze me with their duplicitousness, times 2 of course; but here we are still suffering from their malfeasance in not informing us of the multiple bids for the company. Can these guys please be sent to prison for a long time?
0 · Reply
UgoGreg
UgoGreg Jan. 13 at 5:00 PM
$DVAX https://youtu.be/m61diFB2Pag
0 · Reply